Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-LineTreatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Tria

CMUR > College of Health Care > Department of Respiratory Therapy > Journal articles > Item 310903500/55441

Please use this identifier to cite or link to this item: http://ir.cmu.edu.tw/ir/handle/310903500/55441

Title:	Pemetrexed-Erlotinib, Pemetrexed Alone, or Erlotinib Alone as Second-LineTreatment for East Asian and Non-East Asian Never-Smokers with Locally Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer: Exploratory Subgroup Analysis of a Phase II Tria
Authors:	(Lee DH);(Lee JS);(Wang J);夏德椿(Te-Chun Hsia);(Wang X);(Kim J);(Orlando M)*
Contributors:	健康照護學院二年制呼吸治療學系;中國附醫重症醫學中心
Keywords:	Nonsquamous non-small cell lung cancer, East Asian, Pemetrexed, Erlotinib
Date:	2014-11
Issue Date:	2015-12-30 09:03:18 (UTC+8)
Relation:	Cancer Research and Treatment 0(0):0-0
Appears in Collections:	[Department of Respiratory Therapy] Journal articles

Files in This Item:

File	Description	Size	Format
AA-EK00_20150521124907.docx		42Kb	Microsoft Word	73	View/Open
index.html		0Kb	HTML	76	View/Open